The CU Anschutz IBD Biobank has partnered with health-tech startup Network.Bio to expand its collection and analysis of gut tissue samples, aiming to accelerate research into inflammatory bowel disease and other gastrointestinal conditions.
The collaboration will enable the biobank to proactively collect more patient samples, improve data infrastructure, and leverage advanced analytics to uncover new insights into gut diseases. Researchers believe the expanded biobank could help identify new therapeutic targets, including treatments for complications such as intestinal fibrosis in Crohn’s disease, ultimately supporting the development of more effective GI therapies.